https://www.selleckchem.com/pr....oducts/BIX-02189.htm
001). One HU decrement in SMD was associated with 10% elevated odds of low jump power (adjusted OR [aOR] 1.10, p less then 0.001) after adjusting for age, sex, height, inflammation, and insulin resistance markers, whereas the association of SMA with low jump power was attenuated (aOR 1.00, p = 0.721). SMD showed better discrimination for low jump power than SMA (AUC 0.699 vs. 0.617, p less then 0.001), with additional improvement when added to SMA and conventional risk factors (AUC 0.745 to 0.773, p less then 0.001). Therefore,